Abstract
ATTEMPTS to isolate the human hepatitis viruses in tissue culture have resulted in a collection of “hepatitis-candidate” viruses, none of which has since been shown to be the causal agent of human hepatitis1. The discovery of Australia antigen provided a specific serological marker of infection with or carriage of the serum hepatitis virus, although the nature of the antigen remains unsettled2.
Similar content being viewed by others
Article PDF
References
Zuckerman, A. J., Virus Diseases of the Liver, 46 (Butterworth, London, 1970).
Memorandum: Tests for Australia (hepatitis-associated) antigen and antibody, Bull. Wld Hlth Org., 42, 957 (1970).
Zuckerman, A. J., Nature, 223, 569 (1969).
Brighton, W. D., Taylor, P. E., and Zuckerman, A. J., Nature New Biology, 232, 57 (1971).
Coyne, V. E., Millman, I., and Blumberg, B. S., Bacteriol. Proc. (Abstr.), 175 (1971).
Baines, P. M., Taylor, P. E., and Zuckerman, A. J., Arch. Ges. Virusforsch. (in the press).
Zuckerman, A. J., Vox Sang., 19, 304 (1970).
Zuckerman, A. J., and Taylor, P. E., Nature, 223, 81 (1969).
Almeida, J. D., and Waterson, A. P., Adv. Virus Res., 15, 307 (1969).
Dane, D. S., Cameron, C. H., and Briggs, M., Lancet, i, 695 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ZUCKERMAN, A., BAINES, P. & ALMEIDA, J. Australia Antigen as a Marker of Propagation of the Serum Hepatitis Virus in Liver Cultures. Nature 236, 78–81 (1972). https://doi.org/10.1038/236078a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/236078a0
This article is cited by
-
Cancer Immunotherapy and Nanomedicine
Pharmaceutical Research (2011)
-
The antitumor effects of interferon
Medical Oncology and Tumor Pharmacotherapy (1986)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.